Placental cadherin (P-cadherin) is a classical cadherin \[[@B1]\] expressed by myoepithelial cells of the human mammary gland \[[@B2],[@B3]\]. Changes to P-cadherin expression have been observed and implicated in human breast carcinogenesis \[[@B4]-[@B6]\]. Feline mammary tumours show similarities with the women tumours concerning many histological characteristics and clinical evolution, being proposed as good animal model to study mammary carcinogenesis \[[@B7]\].

To study P-cadherin expression in feline mammary gland an immunohistochemistry assay was performed in 61 samples of normal (*n* = 4), hyperplastic (*n* = 12), benign (*n* = 6) and malignant (*n* = 39) feline mammary tissues and the immunostaining assessment was based on the estimated percentage of luminal epithelial cells labeling (aberrant expression).

In normal mammary gland, mammary hyperplasia and benign tumours, P-cadherin immunolabelling was restricted to myoepithelial cells. Nevertheless, in malignant tumours there was an aberrant epithelial P-cadherin immunoexpression in 64,1% (*n* = 25) of the cases, with a membranar and/or cytoplasmic pattern of cellular distribution. Consequently, P-cadherin expression in feline mammary lesions was not exclusive of myoepithelial cells.

It was possible to observe a significant statistical correlation between P-cadherin expression intensity and feline mammary lesions (p = 0.0001). In malignant mammary tumors a statistical correlation between P-cadherin immunoexpression intensity and histological grade was observed (p = 0.0132). Aberrant epithelial P-cadherin expression seems to be correlated with tumor malignancy in feline mammary gland.
